Manne, Sireesha
Kondru, Naveen
Hepker, Monica
Jin, Huajun
Anantharam, Vellareddy
Lewis, Mechelle
Huang, Xuemei
Kanthasamy, Arthi
Kanthasamy, Anumantha G.
Funding for this research was provided by:
National Center for Advancing Translational Sciences (TL1 TR002016, UL1 TR000127)
National Institutes of Health (ES026892, NS088206)
National Institutes of Health (NS100090, NS060722, NS082151)
Michael J. Fox Foundation for Parkinson's Research
U.S. Department of Defense (PD170118)
Article History
Received: 21 November 2018
Accepted: 10 January 2019
First Online: 31 January 2019
Compliance with ethical standards
:
: A.G.K. and V.A. have an equity interest in PK Biosciences Corporation located in Ames, IA. The terms of this arrangement have been reviewed and approved by Iowa State University in accordance with its conflict of interest policies. Other authors declare no actual or potential competing financial interests.
: CSF samples were collected as part of the NINDS Parkinson’s Disease Biomarker Program (PDBP) according to guidelines (Rosenthal et al. CitationRef removed) for the lumbar puncture. The protocol was reviewed and approved by the Penn State Hershey Internal Review Board and informed written consent was obtained from all subjects. All brain tissues of human subjects were from the University of Miami Brain Endowment Bank and the UC Davis Alzheimer’s Disease Center.